The first and second grid challenges preparing for avian flu drug discovery in mutations have demonstrated that the biomedical communities can be largely benefited from the EGEE infrastructure in terms of the speed and the reaction time of screening over a full spectrum of the compound libraries. Based on Grid Application Platform (GAP)